You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 145 No. 7, July 1991 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (32)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

A Comparative Trial of the Reactogenicity and Immunogenicity of Takeda Acellular Pertussis Vaccine Combined With Tetanus and Diphtheria Toxoids

Outcome in 3- to 8-Month-Old Infants, 9- to 23-Month-Old Infants and Children, and 24- to 30-Month-Old Children

Mikio Kimura, MD; Harumi Kuno-Sakai, MD; Yuji Sato, PhD; Hitoshi Kamiya, MD; Ritsue Nii, MD; Shin Isomura, MD; Kiyoshi Horiuchi, MD; Tatsuo Kato, MD; Masanori Deguchi, MD; Hiroaki Saikusa, MD; Edward A. Mortimer, Jr, MD; James D. Cherry, MD

Am J Dis Child. 1991;145(7):729-733.


Abstract



• The reactogenicity and immunogenicity of the Takeda acellular pertussis vaccine combined with tetanus and diphtheria toxoids were compared in 139 infants aged 3 to 8 months, 60 infants and children aged 9 to 23 months, and 99 children aged 24 to 30 months. Good antibody responses to pertussis toxin (PT), filamentous hemagglutinin (FHA), and agglutinogens occurred in all age groups after both the third and fourth doses. After the fourth (booster) dose, the mean antibody values in initially seronegative infants vaccinated at 3 to 8 months of age were as follows: anti-PT, 67.8 enzyme-linked immunosorbent assay units (EU) per milliliter; anti-FHA, 149.5 EU/mL; the agglutinin titer was 125.6. The values in initially seronegative children vaccinated at 24 to 30 months of age were as follows: anti-PT, 92.9 EU/mL; anti-FHA, 251.7 EU/mL; the agglutinin titer was 275.8. Reactions following immunization were minimal. Except for drowsiness after the first dose in infants, there were no clinically significant differences in reactions between infants and older children. The findings in this study coupled with the recent demonstration of efficacy of this vaccine in 2-year-old children supports the recent Japanese recommendation to lower the age of immunization with acellular pertussis vaccine combined with tetanus and diphtheria toxoids to 3 months.

(AJDC. 1991;145:734-741)



Author Affiliations



From the Department of Pediatrics, Tokai University School of Medicine, Isehara; Japan (Drs Kimura and Kuno-Sakai), the Department of Pediatrics, Mie National Hospital, Tsu, Japan (Drs Kamiya and Nii), Aichi Prefectural Institute of Public Health, Nagoya, Japan (Dr Isomura), Department of Pediatrics, National Higashi-Tochigi Hospital, Utsunomiya, Japan (Dr Horiuchi), Deguchi Pediatrics Clinic, Omura, Japan (Dr Deguchi), and Saikusa Pediatrics Clinic, Sasebo, Japan (Dr Saikusa), Department of Bacteriology, National Institutes of Health, Tokyo, Japan (Dr Sato); Department of Pediatrics, St Marianna University, Kawasaki, Japan (Dr Kato); Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio (Dr Mortimer); and Department of Pediatrics, UCLA School of Medicine (Dr Cherry).


Footnotes



Accepted for publication November 12, 1990.

Reprint requests to Tokai University School of Medicine, Department of Pediatrics, Isehara, Kanagawa, Japan (Dr Kimura).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Financing of Pediatric Home Health Care
Committee on Child Health Financing, Section on Ho
Pediatrics 2006;118:834-838.
ABSTRACT | FULL TEXT  

Statement on Home Care for Patients with Respiratory Disorders
Am. J. Respir. Crit. Care Med. 2005;171:1443-1464.
FULL TEXT  

Integrated Health System for Chronic Disease Management: Lessons Learned From France
Stuart and Weinrich
Chest 2004;125:695-703.
ABSTRACT | FULL TEXT  

Current status of long term ventilation of children in the United Kingdom: questionnaire survey
Jardine et al.
BMJ 1999;318:295-299.
ABSTRACT | FULL TEXT  

Prolonged mechanical ventilation as a consequence of acute illness
Fraser et al.
Arch. Dis. Child. 1998;78:253-256.
ABSTRACT | FULL TEXT  

Interactive Communication in High-technology Home Care: Videophones for Pediatric Ventilatory Care
Miyasaka et al.
Pediatrics 1997;99:e1-e1.
ABSTRACT | FULL TEXT  

Study aims to set up national database of children receiving ventilatory support
Jardine and Wallis
BMJ 1996;313:940b-941.
FULL TEXT  

Case management of technology- dependent children: A family- centered approach
Hill and Thompson
Home Health Care Management Practice 1994;6:37-41.
ABSTRACT  

HOME CARE FOR RESPIRATORY-TECHNOLOGY-DEPENDENT CHILDREN
JWatch General 1991;1991:6-6.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.